Case number 1:22-cv-00297
Novo Nordisk Inc. et al v. Zydus Worldwide DMCC et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 8, 2022 | 33 | NOTICE of Appearance by Alexis Stombaugh on behalf of Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC (Stombaugh, Alexis) (Entered: 12/08/2022) (3) |
| Nov 3, 2022 | 32 | NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-73) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) (Entered: 11/03/2022) (2) |
| Oct 20, 2022 | 31 | NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Initial Noninfringement Contentions filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) (Entered: 10/20/2022) (2) |
| Oct 7, 2022 | 30 | NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-12) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) (Entered: 10/07/2022) (2) |
| Aug 11, 2022 | 29 | NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-10) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) (Entered: 08/11/2022) (2) |
| Aug 5, 2022 | 28 | CERTIFIED TRANSFER ORDER - issued by the Panel on Multi-District Litigation on 08/05/2022 - Associated DE Cases: CA 22-cv-294-CFC, CA 22-cv-296-CFC, CA 22-cv-297-CFC, CA 22-cv-298-CFC, CA 22-cv-299-CFC.(smg) (Entered: 08/08/2022) (5) |
| Jun 30, 2022 | 27 | Scheduling Order (30) Docket Text: SCHEDULING & CONSOLIDATION ORDER: These cases are consolidated for all purposes and all future filings shall be made in Lead Case No. 22-294-CFC ONLY. Joinder of Parties due by 8/1/2023. Amended Pleadings due by 8/1/2023. Fact Discovery completed by 10/20/2023. Expert Discovery due by 5/24/2024. Joint Claim Construction Brief due by 5/1/2023. A Markman Hearing is set for 6/29/2023 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 8/29/2024. A Final Pretrial Conference is set for 9/19/2024 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 9/30/2024 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 6/29/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC(nmf) |
| Jun 30, 2022 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:22-cv-00294-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 22-294-CFC ONLY. (nmf) |
| Jun 29, 2022 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 6/29/2022. (Court Reporter Bonnie Archer.) Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC(nmf) |
| Jun 27, 2022 | 26 | [Proposed] Scheduling Order (38) |
| Jun 27, 2022 | 26 | Main Document (1) Docket Text: Letter to The Honorable Colm F. Connolly from Brian P. Egan regarding the Court's June 6, 2022 Order - re (19 in 1:22-cv-00294-CFC, 21 in 1:22-cv-00298-CFC, 19 in 1:22-cv-00296-CFC, 20 in 1:22-cv-00299-CFC, 25 in 1:22-cv-00297-CFC) Order Setting Scheduling Conference,. (Attachments: # (1) [Proposed] Scheduling Order)(Egan, Brian) |
| Jun 6, 2022 | 25 | Order Setting Scheduling Conference (3) Docket Text: Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 6/29/2022 at 04:00 PM Telephonically before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 6/6/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC(nmf) |
| Jun 3, 2022 | 24 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Brian P. Egan regarding coordinated discovery and Markman proceedings - re (13 in 1:22-cv-00296-CFC, 13 in 1:22-cv-00296-CFC, 15 in 1:22-cv-00294-CFC, 15 in 1:22-cv-00294-CFC, 19 in 1:22-cv-00297-CFC, 19 in 1:22-cv-00297-CFC, 15 in 1:22-cv-00299-CFC, 15 in 1:22-cv-00299-CFC, 17 in 1:22-cv-00298-CFC, 17 in 1:22-cv-00298-CFC) Order,,, Set Deadlines,,. (Egan, Brian) |
| Jun 1, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney David B. Abramowitz, Carolyn A. Blessing, Jacob C. Britz, Michael J. Gaertner, and August M. Melcher for Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., and Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| May 25, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [23] MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, David B. Abramowitz, Carolyn A. Blessing, August M. Melcher and Jacob C. Britz, filed by Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited. Ordered by Judge Colm F. Connolly on 5/25/2022. (kmd) |
| May 24, 2022 | 23 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, David B. Abramowitz, Carolyn A. Blessing, August M. Melcher and Jacob C. Britz - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Kraman, Pilar) |
| May 24, 2022 | 22 | Notice Requesting Removal of Co-Counsel (7) Docket Text: NOTICE requesting Clerk to remove Kara Czekai as co-counsel. Reason for request: No longer with firm. (Egan, Brian) |
| May 19, 2022 | 21 | Order on Motion for Miscellaneous Relief (2) Docket Text: ORDER granting [20] MOTION Change Name of Defendant Cadila Healthcare Limited to Zydus Lifesciences Limited [Unopposed]. Signed by Judge Colm F. Connolly on 5/19/2022. (kmd) |
| May 19, 2022 | 20 | Text of Proposed Order (2) |
| May 19, 2022 | 20 | Main Document (4) Docket Text: MOTION Change Name of Defendant Cadila Healthcare Limited to Zydus Lifesciences Limited [Unopposed] - filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Attachments: # (1) Text of Proposed Order)(Kraman, Pilar) |
| May 11, 2022 | 19 | Order (3) Docket Text: ORDER: IT IS ORDERED that, on or before June 13, 2022, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 6/13/2022.) Signed by Judge Colm F. Connolly on 5/11/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC(nmf) |
| May 9, 2022 | 17 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zydus Lifesciences Limited for Zydus Worldwide DMCC filed by Zydus Worldwide DMCC. (Kraman, Pilar) |
| May 9, 2022 | 18 | Main Document (1) Docket Text: Letter to The Honorable Colm F. Connolly from Brian P. Egan regarding JPML filing. (Attachments: # (1) Attachment)(Egan, Brian) |
| May 9, 2022 | 18 | Attachment (1209) |
| May 9, 2022 | 16 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zydus Lifesciences Limited for Zydus Pharmaceuticals (USA) Inc. filed by Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) |
| May 9, 2022 | 15 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Cadila Healthcare Ltd.. (Kraman, Pilar) |
| May 9, 2022 | 14 | Answer to Complaint (17) Docket Text: ANSWER to [1] Complaint, and Affirmative Defenses by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) |
| May 6, 2022 | 13 | Motion for Leave to Appear Pro Hac Vice (12) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter, Kara Czekai, and Olivia Wheeling - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) |
| May 6, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:22-cv-00298-CFC, 10 in 1:22-cv-00294-CFC, 13 in 1:22-cv-00297-CFC, 10 in 1:22-cv-00296-CFC, 9 in 1:22-cv-00299-CFC) MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter, Kara Czekai, and Olivia Wheeling, filed by Novo Nordisk A/S, Novo Nordisk Inc. Ordered by Judge Colm F. Connolly on 5/6/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC. (kmd) |
| Mar 14, 2022 | 12 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd. to answer, move or otherwise respond to Plaintiffs Complaint to May 9, 2022 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) |
| Mar 14, 2022 | 11 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novo Nordisk Inc., Novo Nordisk A/S: For Zydus Pharmaceuticals (USA) Inc. waiver sent on 3/10/2022, answer due 5/9/2022. (Egan, Brian) |
| Mar 14, 2022 | 10 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novo Nordisk Inc., Novo Nordisk A/S: For Zydus Worldwide DMCC waiver sent on 3/10/2022, answer due 5/9/2022. (Egan, Brian) |
| Mar 14, 2022 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novo Nordisk Inc., Novo Nordisk A/S: For Cadila Healthcare Ltd. waiver sent on 3/10/2022, answer due 5/9/2022. (Egan, Brian) |
| Mar 14, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] STIPULATION TO EXTEND TIME for Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd. to answer, move or otherwise respond to Plaintiffs Complaint to May 9, 2022, filed by Novo Nordisk A/S, Novo Nordisk Inc. Ordered by Judge Colm F. Connolly on 3/14/2022. (kmd) |
| Mar 9, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:22-cv-00294-CFC through 1:22-cv-00299-CFC (rjb) |
| Mar 4, 2022 | 8 | Summons Issued (2) Docket Text: Summons Issued as to Cadila Healthcare Ltd. on 3/4/2022. (srs) |
| Mar 4, 2022 | 7 | Summons Issued (2) Docket Text: Summons Issued as to Zydus Pharmaceuticals (USA) Inc. on 3/4/2022. (srs) |
| Mar 4, 2022 | 6 | Summons Issued (2) Docket Text: Summons Issued as to Zydus Worldwide DMCC on 3/4/2022. (srs) |
| Mar 4, 2022 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo A/S and Corporate Parent Novo Nordisk US Holdings, Inc. for Novo Nordisk Inc.; Corporate Parent Novo A/S for Novo Nordisk A/S - filed by Novo Nordisk A/S and Novo Nordisk Inc. (srs) |
| Mar 4, 2022 | 1 | Complaint* (1) |
| Mar 4, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,132,239 B2 ;10,335,462 B2. (srs) |
| Mar 4, 2022 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/01/2022. Date of Expiration of Patent: U.S. Patent No. 9,132,239 expires 2/1/2032 and U.S. Patent No. 10,335,462 expires on 6/21/2033.Thirty Month Stay Deadline: 6/5/2025. (srs) |
| Mar 4, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs) |
| Mar 4, 2022 | 1 | Civil Cover Sheet (1) |
| Mar 4, 2022 | 1 | Exhibit A (35) |
| Mar 4, 2022 | 1 | Main Document (9) Docket Text: COMPLAINT filed against Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3817668.) - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(srs) |
